elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q55113382-2E2E6F13-B350-434C-9D1C-06DED0D86748
Q55113382-2E2E6F13-B350-434C-9D1C-06DED0D86748
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55113382-2E2E6F13-B350-434C-9D1C-06DED0D86748
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
P2860
Q55113382-2E2E6F13-B350-434C-9D1C-06DED0D86748
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55113382-2E2E6F13-B350-434C-9D1C-06DED0D86748
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47ac929a1f555c4b60d7620450421f70e9b5add4
P2860
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial.